A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT06164704 · COMPLETED
Trial details
- NCT number
- NCT06164704
- Sponsor
- Upstream Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-18
- Primary completion
- 2025-07-07
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.